JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
KROS - Keros Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary KROS Stock
Financials
Financials KROS Stock
Loading...
Loading...
Income Statement
Income Statement KROS Stock
Balance Sheet
Balance Sheet KROS Stock
Cash Flow Statement
Cash Flow Statement KROS Stock
Loading...
Loading...
KROS Financials - Keros Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Keros Therapeutics, Inc. (KROS)
Financials
Financials of KROS
Loading...
Loading...
Loading...
Loading...
Revenue
$243.864M
Operating Income
$67.569M
Net Income
$87.014M
Share Count (Basic)
37.221211M
Operating Cash Flow
$107.505M
Free Cash Flow
$105.954M
Cash And Short-Term Equivalents
$287.415M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
200M
250M
FY2021
FY2022
FY2023
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-200M
-100M
0
100M
Annual
Quarterly
Margins
Gross
Operating
Net
-100000%
-50000%
0%
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
50M
100M
150M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-80000%
-60000%
-40000%
-20000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26